{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:46:03Z","timestamp":1773182763955,"version":"3.50.1"},"reference-count":68,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Fund of Seoul St. Mary\u2019s Hospital, The Catholic University of Korea","award":["ZC25RISI0052"],"award-info":[{"award-number":["ZC25RISI0052"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Systemic hydrocortisone (HCS) in very low birth weight (VLBW) infants is commonly used to treat early hypotension or prevent bronchopulmonary dysplasia. This study evaluated the associations between postnatal HCS exposure and neurodevelopment in VLBW infants by comparing regional brain volume at term-equivalent age (TEA) with neurodevelopmental outcomes in early infancy. Methods: This retrospective cohort study included VLBW infants admitted to a neonatal intensive care unit (NICU) between 2013 and 2019. The cumulative HCS dose during hospitalization was recorded, and regional brain volumes were analyzed using magnetic resonance imaging at TEA. Neurodevelopmental outcomes were assessed at a corrected age for prematurity of 18\u201324 months. Results: Among 146 infants, 57 were classified in the high HCS group (&gt;90 mg\/kg) and 89 in the low HCS group (\u226490 mg\/kg HCS). Bronchopulmonary dysplasia, periventricular leukomalacia, and sepsis were more frequent in the high HCS group. Ninety-five infants underwent magnetic resonance imaging, which revealed reduced brain volumes in the high HCS group. At follow-up, cerebral palsy (35.9% vs. 9.1%, p = 0.003), neurodevelopmental impairment (54.0% vs. 23.6%, p = 0.002), and head circumference &lt;10th percentile (64.3% vs. 19.5%, p &lt; 0.001) were more common in the high HCS group. After adjustment, HCS &gt; 90 mg\/kg remained independently associated with cerebral palsy (adjusted odds ratio [aOR] 5.44, p = 0.016) and reduced head circumference (aOR 4.45, p = 0.016). Conclusions: High cumulative HC exposure correlated with reduced brain volume at TEA and adverse neurodevelopmental outcomes at 24 months of age. Careful monitoring of dose and treatment duration is essential to balance therapeutic benefits against potential risks.<\/jats:p>","DOI":"10.3390\/biomedicines13112765","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:59:09Z","timestamp":1763027949000},"page":"2765","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cumulative Hydrocortisone Exposure and Early Brain Volumetrics in Very Low Birth Weight Infants: Associations with Neurodevelopmental Outcomes"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-3581","authenticated-orcid":false,"given":"Min Soo","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1444-6495","authenticated-orcid":false,"given":"Moon-Yeon","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1895-7560","authenticated-orcid":false,"given":"Emi","family":"Tomita","sequence":"additional","affiliation":[{"name":"Artificial Intelligence Research Center, JLK Inc., Seoul 06141, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-3690","authenticated-orcid":false,"given":"Soo-Ah","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-2414","authenticated-orcid":false,"given":"Young-Ah","family":"Youn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-5642","authenticated-orcid":false,"given":"Sae Yun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.siny.2010.03.009","article-title":"Hyperoxia-derived lung damage in preterm infants","volume":"15","author":"Bhandari","year":"2010","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clp.2011.12.010","article-title":"Neonatal blood pressure support: The use of inotropes, lusitropes, and other vasopressor agents","volume":"39","author":"Noori","year":"2012","journal-title":"Clin. Perinatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics (2010). Policy statement\u2014Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics, 126, 800\u2013808.","DOI":"10.1542\/peds.2010-1534"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e221947","DOI":"10.1001\/jamanetworkopen.2022.1947","article-title":"Dexamethasone, prednisolone, and methylprednisolone use and 2-year neurodevelopmental outcomes in extremely preterm infants","volume":"5","author":"Wood","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/adc.69.3_Spec_No.284","article-title":"Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweight infants","volume":"69","author":"Gill","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jp.7210563","article-title":"Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs","volume":"21","author":"Pursley","year":"2001","journal-title":"J. Perinatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00467-006-0311-3","article-title":"Blood pressure in non-critically ill preterm and full-term neonates","volume":"22","author":"Pejovic","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00431-013-2251-9","article-title":"International survey on diagnosis and management of hypotension in extremely preterm babies","volume":"173","author":"Stranak","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpeds.2008.09.017","article-title":"Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants","volume":"154","author":"Batton","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1865","DOI":"10.1542\/peds.2012-2779","article-title":"Use of antihypotensive therapies in extremely preterm infants","volume":"131","author":"Batton","year":"2013","journal-title":"Pediatrics"},{"key":"ref_12","first-page":"238","article-title":"Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants","volume":"95","author":"Goldstein","year":"1995","journal-title":"Pediatrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-3782(89)90120-5","article-title":"Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants","volume":"19","author":"Watkins","year":"1989","journal-title":"Early Hum. Dev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1136\/archdischild-2015-309814","article-title":"Treating hypotension in extremely preterm infants. The pressure is mounting","volume":"101","author":"Barrington","year":"2016","journal-title":"Arch. Dis. Child.-Fetal Neonatal Ed."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1651-2227.2011.02545.x","article-title":"Inotropes in preterm infants\u2013evidence for and against","volume":"101","author":"Cox","year":"2012","journal-title":"Acta Paediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.jp.7211579","article-title":"Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant","volume":"26","author":"Dempsey","year":"2006","journal-title":"J. Perinatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1136\/fn.84.2.F122","article-title":"Refractory hypotension in preterm infants with adrenocortical insufficiency","volume":"84","author":"Ng","year":"2001","journal-title":"Arch. Dis. Child.-Fetal Neonatal Ed."},{"key":"ref_18","first-page":"CD001146","article-title":"Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"10","author":"Cheong","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_19","first-page":"CD001145","article-title":"Late (\u22657 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"11","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1542\/peds.95.1.120","article-title":"Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia","volume":"95","author":"Watterberg","year":"1995","journal-title":"Pediatrics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM198906083202301","article-title":"A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia","volume":"320","author":"Cummings","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e206826","DOI":"10.1001\/jamapediatrics.2020.6826","article-title":"Assessment of postnatal corticosteroids for the prevention of bronchopulmonary dysplasia in preterm neonates: A systematic review and network meta-analysis","volume":"175","author":"Ramaswamy","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.75.1.106","article-title":"Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia","volume":"75","author":"Avery","year":"1985","journal-title":"Pediatrics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF01956753","article-title":"Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone","volume":"152","author":"Fauser","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.jp.7200202","article-title":"Low serum cortisol in term newborns with refractory hypotension","volume":"19","author":"Tantivit","year":"1999","journal-title":"J. Perinatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.104.1.22","article-title":"Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age","volume":"104","author":"Kothadia","year":"1999","journal-title":"Pediatrics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.jp.7200520","article-title":"Focal small bowel perforation: An adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants","volume":"21","author":"Gordon","year":"2001","journal-title":"J. Perinatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1542\/peds.104.5.e63","article-title":"Dexamethasone therapy increases infection in very low birth weight infants","volume":"104","author":"Stoll","year":"1999","journal-title":"Pediatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000286210","article-title":"Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: A systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jpeds.2014.06.009","article-title":"Trends in pharmacotherapy for neonatal hypotension","volume":"165","author":"Rios","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00431-019-03398-5","article-title":"Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: A systematic review and meta-analysis","volume":"178","author":"Morris","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ramaswamy, V.V., Kumar, G., Pullattayil, S.A.K., Aradhya, A.S., Suryawanshi, P., Sahni, M., Khurana, S., Saini, S.S., K, R., and Dhir, S.K. (2025). Timing of hydrocortisone therapy in neonates with shock: A systematic review, meta-analysis, and clinical practice guideline. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1491976"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2017.2692","article-title":"Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age","volume":"317","author":"Baud","year":"2017","journal-title":"JAMA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000098168","article-title":"Early low-dose hydrocortisone in very preterm infants: A randomized, placebo-controlled trial","volume":"91","author":"Bonsante","year":"2007","journal-title":"Neonatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","article-title":"Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): A double-blind, placebo-controlled, multicentre, randomised trial","volume":"387","author":"Baud","year":"2016","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.2018.21443","article-title":"Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: A randomized clinical trial","volume":"321","author":"Onland","year":"2019","journal-title":"JAMA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2021.9380","article-title":"Effect of systemic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years\u2019 corrected age: Follow-up of a randomized clinical trial","volume":"326","author":"Halbmeijer","year":"2021","journal-title":"JAMA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa2114897","article-title":"Hydrocortisone to improve survival without bronchopulmonary dysplasia","volume":"386","author":"Watterberg","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jpeds.2013.04.001","article-title":"Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants","volume":"163","author":"Kersbergen","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpeds.2006.10.051","article-title":"Neonatal hydrocortisone treatment: Neurodevelopmental outcome and MRI at school age in preterm-born children","volume":"150","author":"Rademaker","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"148703","DOI":"10.1016\/j.brainres.2023.148703","article-title":"Volumetric changes in brain MRI of infants with hypoxic-ischemic encephalopathy and abnormal neurodevelopment who underwent therapeutic hypothermia","volume":"1825","author":"Im","year":"2024","journal-title":"Brain Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1297\/cpe.2022-0009","article-title":"Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)","volume":"31","author":"Ishii","year":"2022","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"NHBPE Program (2000). Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol., 183, s1\u2013s22.","DOI":"10.1067\/mob.2000.107928"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(95)90028-4","article-title":"Amniotic fluid interleukin-6: A sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity","volume":"172","author":"Yoon","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Fenton, T.R., and Kim, J.H. (2013). A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr., 13.","DOI":"10.1186\/1471-2431-13-59"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Ann. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"J. Pediatr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An international classification of retinopathy of prematurity","volume":"102","author":"Garner","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1542\/peds.2004-1915","article-title":"Age terminology during the perinatal period","volume":"114","author":"Engle","year":"2004","journal-title":"Pediatrics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00431-008-0775-1","article-title":"Relationship among the Manual Ability Classification System (MACS), the Gross Motor Function Classification System (GMFCS), and the functional status (WeeFIM) in children with spastic cerebral palsy","volume":"168","author":"Gunel","year":"2009","journal-title":"Eur. J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1542\/peds.2006-0661","article-title":"Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates","volume":"118","author":"Noori","year":"2006","journal-title":"Pediatrics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1542\/peds.107.5.1070","article-title":"Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension","volume":"107","author":"Seri","year":"2001","journal-title":"Pediatrics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jp.2009.126","article-title":"Hydrocortisone for hypotension and vasopressor dependence in preterm neonates: A meta-analysis","volume":"30","author":"Higgins","year":"2010","journal-title":"J. Perinatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1203\/00006450-199501000-00021","article-title":"Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants","volume":"37","author":"Scott","year":"1995","journal-title":"Pediatr. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/jp.2014.151","article-title":"Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation","volume":"35","author":"Noori","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/jp.2008.190","article-title":"ACTH and cortisol response to critical illness in term and late preterm newborns","volume":"28","author":"Fernandez","year":"2008","journal-title":"J. Perinatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejpn.2011.05.002","article-title":"Exogenous glucocorticoids and adverse cerebral effects in children","volume":"15","author":"Damsted","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e20161640","DOI":"10.1542\/peds.2016-1640","article-title":"Third trimester brain growth in preterm infants compared with in utero healthy fetuses","volume":"138","author":"McCarter","year":"2016","journal-title":"Pediatrics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e230198","DOI":"10.1001\/jamanetworkopen.2023.0198","article-title":"Association of brain microstructure and functional connectivity with cognitive outcomes and postnatal growth among early school\u2013aged children born with extremely low birth weight","volume":"6","author":"Kim","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/jp.2014.133","article-title":"Neurodevelopmental impact of hydrocortisone exposure in extremely low birth weight infants: Outcomes at 1 and 2 years","volume":"35","author":"Patra","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1542\/peds.2006-3158","article-title":"Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants","volume":"120","author":"Watterberg","year":"2007","journal-title":"Pediatrics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41372-023-01729-x","article-title":"Use of term reference infants in assessing the developmental outcome of extremely preterm infants: Lessons learned in a multicenter study","volume":"43","author":"Green","year":"2023","journal-title":"J. Perinatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF03061566","article-title":"Postnatale dexamethason en neurologische uitkomst: Een meta-analyse","volume":"73","author":"Onland","year":"2005","journal-title":"Tijdschr. Kindergeneeskd."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Taniguchi, A., Chr\u00e9tien, B., Maeda, T., Ueda, K., Miura, R., Tanaka, R., Suzuki, T., Muramatsu, Y., Kataoka, E., and Kato, E. (2025). Total hydrocortisone dosage in extremely low birth weight infants and neurodevelopment up to school age. Pediatr. Res., 1\u20137.","DOI":"10.1038\/s41390-025-04426-x"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1523\/JNEUROSCI.3479-08.2008","article-title":"A structural MRI study of human brain development from birth to 2 years","volume":"28","author":"Knickmeyer","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_66","first-page":"224","article-title":"Quantitative magnetic resonance imaging of brain development in premature and mature newborns","volume":"43","author":"Warfield","year":"1998","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpeds.2013.10.083","article-title":"Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm","volume":"164","author":"Cheong","year":"2014","journal-title":"J. Pediatr."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2765\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:29:38Z","timestamp":1763029778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":68,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["biomedicines13112765"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13112765","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}